0001127602-23-009493.txt : 20230308 0001127602-23-009493.hdr.sgml : 20230308 20230308190346 ACCESSION NUMBER: 0001127602-23-009493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Santos Esteban CENTRAL INDEX KEY: 0001677950 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 23717670 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-03-06 0000318154 AMGEN INC AMGN 0001677950 Santos Esteban ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 EVP, Operations Common Stock 820.4662 I 401K Plan Common Stock 2023-03-06 4 A 0 7753 0 A 65676 D These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,342 RSUs which vest on 5/3/2023; 2,268 RSUs which vest in installments of 1,117 on 5/5/2023 and 1,151 on 5/5/2024; 3,964 RSUs which vest in two installments of 1,308 on 4/30/2023 and 4/30/2024 and one installment of 1,348 on 4/30/2025; and 3,637 RSUs which will vest in two installments of 1,200 on 5/2/2024 and on 5/2/2025, and one installment of 1,237 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 658 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. /s/ Esteban Santos 2023-03-07